C14orf166 is a high-risk biomarker for bladder cancer and promotes bladder cancer cell proliferation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
C14orf166 is a high-risk biomarker for bladder cancer and promotes bladder cancer cell proliferation ; volume:14 ; number:1 ; day:23 ; month:2 ; year:2016 ; pages:1-10 ; date:12.2016
Journal of translational medicine ; 14, Heft 1 (23.2.2016), 1-10, 12.2016
- Creator
-
Chen, Mingkun
- Contributor
-
Ye, Yunlin
Zou, Baojia
Guo, Suping
Zhou, Fangjian
Lu, Keshi
Liu, Jianye
Xu, Zhenzhou
Han, Hui
Liu, Zhuowei
Li, Yonghong
Yao, Kai
Liu, Cundong
Qin, Zike
SpringerLink (Online service)
- DOI
-
10.1186/s12967-016-0801-4
- URN
-
urn:nbn:de:101:1-2018070322063753657451
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chen, Mingkun
- Ye, Yunlin
- Zou, Baojia
- Guo, Suping
- Zhou, Fangjian
- Lu, Keshi
- Liu, Jianye
- Xu, Zhenzhou
- Han, Hui
- Liu, Zhuowei
- Li, Yonghong
- Yao, Kai
- Liu, Cundong
- Qin, Zike
- SpringerLink (Online service)
Other Objects (12)
CALN1 hypomethylation as a biomarker for high-risk bladder cancer
Bladder cancer
BORA regulates cell proliferation and migration in bladder cancer
Treatment of bladder cancer
Bladder cancer course, four genetic high-risk variants, and histopathological findings
Urinary BLACAT1 as a non-invasive biomarker for bladder cancer
Heterogenous NECTIN4 expression in urothelial high-risk non-muscle-invasive bladder cancer
Heterogenous NECTIN4 expression in urothelial high-risk non-muscle-invasive bladder cancer
New treatments in bladder cancer
Molecular markers in bladder cancer
Advances in bladder cancer imaging
Radiotherapy in metastatic bladder cancer
CALN1 hypomethylation as a biomarker for high-risk bladder cancer
Bladder cancer
BORA regulates cell proliferation and migration in bladder cancer
Treatment of bladder cancer
Bladder cancer course, four genetic high-risk variants, and histopathological findings
Urinary BLACAT1 as a non-invasive biomarker for bladder cancer
Heterogenous NECTIN4 expression in urothelial high-risk non-muscle-invasive bladder cancer
Heterogenous NECTIN4 expression in urothelial high-risk non-muscle-invasive bladder cancer
New treatments in bladder cancer
Molecular markers in bladder cancer
Advances in bladder cancer imaging
Radiotherapy in metastatic bladder cancer
CALN1 hypomethylation as a biomarker for high-risk bladder cancer
Bladder cancer
BORA regulates cell proliferation and migration in bladder cancer
Treatment of bladder cancer
Bladder cancer course, four genetic high-risk variants, and histopathological findings
Urinary BLACAT1 as a non-invasive biomarker for bladder cancer
Heterogenous NECTIN4 expression in urothelial high-risk non-muscle-invasive bladder cancer
Heterogenous NECTIN4 expression in urothelial high-risk non-muscle-invasive bladder cancer
New treatments in bladder cancer
Molecular markers in bladder cancer
Advances in bladder cancer imaging